홈 › 주요우울장애 › 텍사스

텍사스의 주요우울장애 임상 시험

주요우울장애 관련 연구 37개가 텍사스 내 여러 지역에서 참여자를 모집하고 있습니다.

텍사스의 도시

공식 연구 텍스트(영어)

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

Austin Clinical Trial Partners, Austin
FutureSearch Trials of Dallas, Dallas
Revival Research Institute, Llc - McKinney, Tx, McKinney
외 1개

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07621237

A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

John S Dunn Behavioral Sciences Center at UTHealth Houston, Houston

피험자 모집 중3상

12세 ~ 17세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07227454

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Adams Clinical Dallas, DeSoto
Brain Health Consultants and TMS Center, Houston
Flourish Research San Antonio, San Antonio

피험자 모집 중3상

18세 ~ 85세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06793397

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

DM Clinical Research, Houston
Pillar Clinical Research, LLC, Richardson

피험자 모집 중3상

18세 ~ 65세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT05850689

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Houston Clinical Trials LLC, Bellaire
North Texas Clinical Trials, Fort Worth
Baylor College of Medicine, Houston
외 1개

피험자 모집 중3상

18세 ~ 74세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06559306

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

Vanda Investigational Site, Houston
Vanda Investigational Site, Plano
Vanda Investigational Site, Richardson
외 1개

피험자 모집 중3상

18세 ~ 65세 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06830044

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

Neurocrine Clinical Site, Austin

피험자 모집 중4상

18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT07105111

Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression

Wells Medicine, Houston
Texas A&M (Houston Methodist Hospital Location), Houston

피험자 모집 중1상건강한 지원자 환영

21세 ~ 45세 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT06480201

ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

Baylor College of Medicine, Houston
Olympus Clinical Research, LLC, Katy
Family Psychiatry of The Woodlands, The Woodlands

피험자 모집 중2상

18세 ~ 65세 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT07284667

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

Seaport Investigator Site, Dallas
Seaport Investigator Site, Irving
Seaport Investigator Site, Richardson

피험자 모집 중2상

18세 ~ 65세 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT07065240

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

Austin Clinical Trial Partners, Austin

피험자 모집 중3상

18세 ~ 74세 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT07076407

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

Draig Clinical Site, DeSoto
Draig Clinical Site, Fort Worth

피험자 모집 중2상

18세 ~ 75세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT07610473

Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

University of Texas Austin Dell Medical School, Austin
University of Texas Southwestern Medical Center at Dallas, Dallas
CHI St. Luke's Health Baylor College of Medicine Med. Ctr, Houston
외 1개

피험자 모집 중

22세 ~ 70세 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT06423430

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

Draig Clinical Site, Austin
Draig Clinical Site, Austin
Draig Clinical Site, DeSoto
외 2개

피험자 모집 중2상

18세 ~ 75세 · 모든 성별 · 2026. 8. 26. 업데이트됨 · NCT07300969

Accelerated Intermittent Theta Burst in Treatment-Naive Adolescents

Dell Medical School at University of Texas at Austin, Austin

피험자 모집 중

13세 ~ 20세 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT06523439

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Neurocrine Clinical Site, DeSoto

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT06911112

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

Austin Clinical Trial Partners, Austin

피험자 모집 중3상

18세 ~ 74세 · 모든 성별 · 2026. 8. 10. 업데이트됨 · NCT07592689

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

Adams Clinical Dallas, DeSoto
Re:Cognition Health - Fort Worth, Fort Worth
Consano Clinical Research, LLC, Shavano Park

피험자 모집 중3상

18세 ~ 75세 · 모든 성별 · 2026. 8. 6. 업데이트됨 · NCT07412756

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Delricht Research - Plano, Plano
Aim Trials, Llc, Plano
Grayline Research Center, Wichita Falls

피험자 모집 중3상

18세 ~ 74세 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT06775379

Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

Austin Clinical Trial Partners, Austin
InSite Clinical Research, LLC, DeSoto
Grayline Research Center, Wichita Falls

피험자 모집 중2상

18세 ~ 64세 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT06547489

DBS for Depression

University of Texas Southwestern, Dallas

피험자 모집 중

22세 ~ 70세 · 모든 성별 · 2026. 7. 30. 업데이트됨 · NCT03437928

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

Elevate Synapsis, LLC, Atascocita
Synapsis Bio, Atascocita
Adams Clinical Dallas, DeSoto

피험자 모집 중2상

18세 ~ 64세 · 모든 성별 · 2026. 7. 27. 업데이트됨 · NCT07115329

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

Clinical Research Site, Austin
Clinical Research Site, Bellaire
Clinical Research Site, Dallas
외 2개

피험자 모집 중3상

18세 ~ 65세 · 모든 성별 · 2026. 7. 24. 업데이트됨 · NCT07484217

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Neurocrine Clinical Site, Bellaire
Neurocrine Clinical Site, Stafford
Neurocrine Clinical Site, Wichita Falls

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 7. 24. 업데이트됨 · NCT07196501

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Neurocrine Clinical Site, Bellaire
Neurocrine Clinical Site, Dallas
Neurocrine Clinical Site, DeSoto
외 3개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 7. 24. 업데이트됨 · NCT06966401

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

Austin Clinical Trial Partners /ID# 279321, Austin
Community Clinical Research - Cross Park Drive /ID# 277935, Austin
Houston Clinical Trials - Bellaire /ID# 277551, Bellaire
외 1개

피험자 모집 중2상

18세 ~ 65세 · 모든 성별 · 2026. 6. 15. 업데이트됨 · NCT07276997

Triage Survey for Psychiatry Research Eligibility

Adams Clinical, Dallas, DeSoto

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 5. 20. 업데이트됨 · NCT05800925

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

Biobehavioral Research of Austin, Austin
InSite Clinical Research, DeSoto
Aim Trials, LLC, Plano

피험자 모집 중2상

18세 ~ 65세 · 모든 성별 · 2026. 5. 11. 업데이트됨 · NCT06524830

Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia

Houston Center For Advanced Psychiatric Treatment, Houston

피험자 모집 중

22세 ~ 75세 · 모든 성별 · 2026. 5. 1. 업데이트됨 · NCT06982820

Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression

Health Discovery Building (HDB), 1601 Trinity St., Bldg B., Z0600, Austin

피험자 모집 중4상

18세 ~ 65세 · 모든 성별 · 2026. 5. 1. 업데이트됨 · NCT05892744

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

University of Texas Southwestern Medical Center, Dallas

피험자 모집 중관찰 연구

18세 ~ 40세 · 모든 성별 · 2026. 3. 10. 업데이트됨 · NCT06740383

Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)

Autobahn Site #153, Beaumont
Autobahn Site #146, San Antonio
Autobahn Site #144, Sherman

피험자 모집 중2상

18세 ~ 65세 · 모든 성별 · 2026. 1. 20. 업데이트됨 · NCT06633016

Psilocybin rTMS for Treatment Resistant Depression

Health Discovery Building (HDB), 1601 Trinity St., Bldg B., Z0600, Austin

피험자 모집 중2상

22세 ~ 65세 · 모든 성별 · 2025. 11. 26. 업데이트됨 · NCT06132178

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Neurocrine Clinical Site, Dallas
Neurocrine Clinical Site, Houston

피험자 모집 중3상

18세 이상 · 모든 성별 · 2025. 10. 29. 업데이트됨 · NCT06786624

Study of ALTO-300 in MDD

Site 347, Fort Worth
Site 353, Plano
Site 196, Richmond

피험자 모집 중2상

18세 ~ 70세 · 모든 성별 · 2025. 7. 24. 업데이트됨 · NCT05922878

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

Clinical Research Site, Dallas
Clinical Research Site, Dallas
Clinical Research Site, Friendswood
외 2개

피험자 모집 중4상

18세 ~ 65세 · 모든 성별 · 2025. 1. 23. 업데이트됨 · NCT06223880

Neurobehavioral Therapy For Epilepsy And Major Depressive Disorder

Michael E. DeBakey VA Medical Center, Houston
The University of Texas health Science Center at Houston, Houston

피험자 모집 중건강한 지원자 환영

18세 이상 · 모든 성별 · 2025. 1. 9. 업데이트됨 · NCT06695767

ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.